Abstract
Ondansetron is an FDA-approved selective serotonin 5-HT3 receptor
commonly indicated as an anti-emetic agent for nausea and vomiting. It
is rare to observe fatal reactions from ondansetron despite having no
allergies or previous exposure. We report a case of anaphylactoid
reaction with spontaneous coronary vasospasms in response to intravenous
ondansetron.